Clinical Trials Sponsored by Revalidatieziekenhuis RevArte

Total 54 results

Thomas More University of Applied Sciences
Revalidatieziekenhuis RevArte; To Walk Again REVAlution Center

Completed

Immersive Care - Virtual Mirror Therapy

Stroke

Belgium
Revalidatieziekenhuis InkendaaI

Completed

Patient Preference for Mouthpiece Ventilation

Neuromuscular Diseases

Belgium
Universiteit Antwerpen
Rehabilitation Hospital RevArte

Completed

Stroke Walking Explained After Trunk Training (SWEAT²)

Stroke

Belgium
Universiteit Antwerpen
Rehabilitation Hospital RevArte

Completed

Interaction Between Trunk and Gait Performance in Both Healthy Adults and Stroke Patients

Stroke | Healthy | Gait, Hemiplegic

Belgium
Vrije Universiteit Brussel
Universitair Ziekenhuis Brussel; Revalidatieziekenhuis InkendaaI

Not yet recruiting

Strength Training in Hospitalized Patients Using the Ghostly App: a Feasibility Study

Stroke | COVID-19 | Muscle Weakness | Frailty | Sarcopenia

Belgium
Universitaire Ziekenhuizen KU Leuven
Pulderbos revalidatiecentrum; Revalidatieziekenhuis Inkendaal

Recruiting

Evaluation of Macroscopic Muscle Growth in Infants and Young Children With Spastic Cerebral Palsy (3D-MMAP)

Acquired Brain Injury | Spastic Cerebral Palsy

Belgium
Repare Therapeutics

Recruiting

LIONS (PLK4 Inhibitor in Advanced Solid Tumors)

Advanced Solid Tumor

United States
Repare Therapeutics

Active, not recruiting

Study of RP-6306 With FOLFIRI in Advanced Solid Tumors (MINOTAUR)

Advanced Solid Tumor

United States, Canada, Spain, United Kingdom
Repare Therapeutics

Active, not recruiting

Study of RP-6306 With Gemcitabine in Advanced Solid Tumors

Adult Solid Tumor

United States, Canada, United Kingdom
Revance Therapeutics, Inc.

Completed

DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis

Plantar Fasciitis

United States
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Glabellar Frown Lines

United States
Revance Therapeutics, Inc.

Completed

Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines

Glabellar Frown Lines

United States, Canada
Revance Therapeutics, Inc.

Completed

Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines (RADIANT)

Skin Aging

United States
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

Skin Aging

United States
Revance Therapeutics, Inc.

Completed

Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity (JUNIPER)

Upper Limb Spasticity

United States
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines

Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)

United States, Canada
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines

Lateral Canthal Lines

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis

Hyperhidrosis

United States
Revance Therapeutics, Inc.

Terminated

Open Label Study to Assess Long-term Safety of Repeat Administration of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

Skin Aging

United States
Revance Therapeutics, Inc.

Completed

A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Reverse Medical Corporation

Suspended

ReStore Thrombectomy Trial for Flow Restoration in Acute Ischemic Stroke Patients

Ischemic Stroke

United States
Revance Therapeutics, Inc.

Completed

Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis

Plantar Fasciitis

United States
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)

Frown Lines

United States, Canada
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Glabellar Frown Lines

United States, Canada
Revance Therapeutics, Inc.

Active, not recruiting

Teosyal RHA® Histology and Intradermal Implantation Evaluation Study

Histology

Canada
Revance Therapeutics, Inc.

Completed

Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Lateral Canthal Lines

United States
Revance Therapeutics, Inc.

Completed

Dose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical Dystonia

Torticollis (Spasmodic)

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines (REALISE 1)

Skin Aging

United States
Revance Therapeutics, Inc.

Completed

Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines

Glabellar Frown Lines

Canada
Revance Therapeutics, Inc.

Completed

Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults

Facial Wrinkles | Lateral Canthal Lines | Crow's Feet

United States
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Lateral Canthal Lines

United States
Revance Therapeutics, Inc.
Syneos Health

Completed

Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) (ASPEN-1)

Cervical Dystonia

United States, Spain, Germany, Austria, Poland, France, Canada, Czechia, United Kingdom
Revance Therapeutics, Inc.
Syneos Health

Completed

Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS) (ASPEN-OLS)

Cervical Dystonia

United States, Spain, Germany, France, Czechia, Poland, United Kingdom, Canada, Austria
Repare Therapeutics
Debiopharm International SA

Recruiting

Study of RP-6306 Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors (MYTHIC)

Advanced Solid Tumor

United States, Canada, Denmark
University of Utah
Repare Therapeutics

Recruiting

RP-3500 and Olaparib in DNA Damage Repair Pathway Deficient Relapsed/Refractory Chronic Lymphocytic Leukemia (CORONADO CLL)

Chronic Lymphocytic Leukemia

United States
Repare Therapeutics
Roche Pharma AG

Recruiting

Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors (ATTACC)

Advanced Solid Tumor, Adult

United States
Repare Therapeutics
Roche Pharma AG

Active, not recruiting

Study of RP-3500, Camonsertib, in Advanced Solid Tumors

Advanced Solid Tumor

United States, Canada, Denmark, United Kingdom
Tilburg University
Fonds NutsOhra; Revant Schoondonck Center for Pulmonary Rehabilitation Breda; Revant Innovation foundation

Completed

Pulmonary Rehabilitation: Effects on Cognitive Functioning, Mood, Anxiety, and Quality of Life in Patients With COPD

Chronic Obstructive Pulmonary Disease COPD

Netherlands
Canadian Cancer Trials Group
Repare Therapeutics

Recruiting

RP-6306 in Patients With Advanced Cancer

Advanced Cancer

Canada
Revance Therapeutics, Inc.
Wake Forest University Health Sciences

Terminated

DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis

Plantar Fasciitis

United States
Memorial Sloan Kettering Cancer Center
Repare Therapeutics

Recruiting

A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer

Solid Tumor | Metastatic Cancer

United States
Dr. Renate List

Completed

ATTUNE TM Video-fluoroscopy Study

Total Knee Arthroplasty

Switzerland
Dr. Renate List

Completed

Total Knee Arthroplasty Videofluoroscopy

Total Knee Anthroplasty

Switzerland
Ki Health Partners. LLC
Revance Therapeutics, Inc.; The Los Angeles Headache Center

Recruiting

An Open Label, Study of DaxibotulinumtoxinA for Migraine Prevention

Migraine Disorders

United States
Ki Health Partners. LLC
Revance Therapeutics, Inc.; The Los Angeles Headache Center

Recruiting

Open Label, 6-month Study for High Frequency and Chronic Migraine,

Chronic Migraine, Headache

United States
Dr. Renate List
Balgrist University Hospital; Kantonsspital Winterthur KSW

Completed

Understanding GMK Sphere Implant Tibiofemoral Kinematics by Means of Dynamic Videofluoroscopy

Total Knee Arthroplasty | Tibiofemoral Kinematics

Switzerland

Clinical Trials Sponsored by Revalidatieziekenhuis RevArte

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations